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1. Introduction 
Serum iron is transported bound to transferrin. 
The transferrin molecule can bind a maximum of two 
atoms of iron in the ferric form with concomitant 
binding of carbonate or bicarbonate ion (reviewed in 
[ 11). The iron bound to transferrin can be taken up 
by many different cell types; inside the cell the iron 
is incorporated into the storage form, ferritin, and 
may also be used for the synthesis of iron-containing 
haem and non-haem enzymes. From studies, mostly 
carried out with reticulocytes, it has been established 
that subsequent o the binding of transferrin to 
specific receptors on the plasma membrane the trans- 
ferrin molecule is internalised by endocytosis and the 
iron is released [2,3]. The precise mechanism and site 
of iron release remains unclear, and it is at present not 
established whether interiorisation of the transferrin 
molecule precedes or is a subsequent event to iron 
release. It has been proposed [4] that subsequent 
to endocytosis of the transferrin-receptor complex 
iron would be released in endocytic vacuoles while 
the iron-depleted protein would be returned to the 
extracellular medium. In view of the lability of trans- 
ferrin iron at acid pH values another mechanism can 
be envisaged. Studies on the fate of antibodies 
directed against the plasma membrane of cultured 
rat fibroblasts lead [5] to the conclusion that plasma 
membrane fragments, after interiorisation, gain access 
to lysosomes and could thereafter be recycled back to 
the cell surface. By analogy with these results we pro- 
pose that the transferrin molecule, after binding and 
internalisation in endocytic vacuoles, gains access to 
lysosomes where its iron is released, and the transferrin 
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molecule is returned to the cell surface and discharged 
into the extracellular medium. Results compatible 
with this hypothesis have been obtained in experi- 
ments using rat fibroblasts in culture [6]. 
We report here on experiments which show that 
cultured rat fibroblasts accumulate transferrin iron, 
and that a number of drugs which affect endocytosis 
and lysosomal function or which chelate free iron (but 
not directly transferrin or ferritin iron) greatly reduce 
iron uptake from transferrin.by fibroblasts without 
significantly affecting accumulation of transferrin 
protein. 
2. Materials and methods 
Rat serum transferrin was purified by a modifica- 
tion of the method in [7] using (NH&SO4 precipita- 
tion, DEAE-cellulose chromatography, chromato- 
graphy on Sepharose-protein A and a final chromato- 
graphy on CM-celhrlose [6]. Transferrin was labelled 
with ‘H by reductive methylation [8] using sodium 
[‘Hlborohydride and the apotransferrin was labelled 
with 59Fe as ferric citrate in order to have a specific 
activity close to that for 3H 161. The transferrin was 
subsequently saturated with non-radioactive iron to 
give a Atis/Assa ratio of 0.046 [9]. Rat embryo 
fibroblasts were prepared and cultivated as in [IO]. 
The culture medium was supplemented with 10% 
newborn calf serum (NBCS). The cells were incu- 
bated at 37°C with labelled transferrin at 100 pg/ml 
final cont. and after incubation the medium was 
removed, the cells washed 4 times with phosphate- 
buffered saline (PBS), once with culture medium 
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containing 10Y0 NBCS, twice with PBS to detach 
seric protein simply adsorbed, and solubilised with 
1 YO (w/v) sodium deoxycholate adjusted to pH 11.3 
with NaOH. The radioactivity accumulated by the 
cells was measured using an Aqualuma cocktail in a 
Packard liquid scintillation counter. All samples were 
corrected for quenching. Cell protein was determined 
by the Lowry method [l 11. The results are expressed 
as dpm/mg cell protein. The drugs were employed 
at the final concentrations given in section 3 (all of 
which were sub-toxic for the cells) throughout the 
incubation. 
3. Results and discussion 
That rat fibroblasts in culture accumulate trans- 
ferrin iron and transferrin protein is apparent from 
fig.1. At 37°C iron uptake proceeds linearly over the 
entire period of incubation studied (24 h). In contrast, 
accumulation of ‘H-labelled material increases linearly 
up to -6 h, then reaches a plateau. Since the specific 
activities of 3H and 59Fe are very similar at the start 
of the incubation, these results establish that fibro- 
blasts accumulate considerably more 59Fe than 3H. 
After 24 h much of the 59Fe is associated with cytosol 
ferritin [6] and the difference between the accumula- 
tion of iron and protein cannot be explained by the 
digestion of the transferrin and the release of degrada- 
tion products into the extracellular medium [6]. 
Desferrioxamine B, 2,3dihydroxybenzoate and 
2,2’-bipyridyl are all iron chelators. At final concen- 
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Fig.1. Kinetics of accumulation of ‘9Fe (0) and 3H (0) 
-labelled material by fibroblasts. Cells (-300 pg protein) 
were incubated in 7 cm* plastic Petri dishes, in 0.3 ml culture 
medium supplemented with 10% calf serum and containing 
100 pg/ml of 59Fe-loaded, 3H-labelled transferrin for various 
times at 37’C. Mean results of 12 expt f SD. 
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Fig.2. Kinetics of accumulation of 59Fe (0) and ‘H (0) 
-labelled material by fibroblasts. Cells (-300 I.rg protein) 
were incubated in 7 cm* Petri dishes, in 0.3 ml culture medium 
containing 100 clg/ml 59Fe-loaded, “H-labelled transferrin and 
50 pM 2,2’-bipyridyl (A), 1 mM 2,3-dihydroxybenzoate (B), 
or 50 crM desferrioxamine B (C), for various times at 37’C. 
Mean results of 3 expt k SD. 
trations of 50 PM, 1 mM and 50 PM, respectively, 
they all greatly reduce uptake of 5YFe without a 
correspondingly important effect on 3H accumula- 
tion (fig.2). For all three chelators iron accumulation 
proceeds at a rate which is not markedly below con- 
trol values for the first 4-6 h and then slows down 
considerably. None of these three drugs is an effec- 
tive chelator of transferrin or of ferritin iron [ 12,131. 
The possible mode of action is discussed further below. 
Chloroquine and methylamine are weak bases 
which accumulate in lysosomes [ 141. Their effects on 
iron and 3H accumulation in fibroblasts incubated with 
doubly-labelled transferrin are illustrated in fig.3. At 
10 PM chloroquine has no effect either on SYFe or on 
3H accumulation. At 100 PM chloroquine substantially 
reduces the rate of 59Fe accumulation, without any 
significant effect on 3H uptake. Interestingly, in con- 
trast to the iron chelators used (fig.2) 59Fe uptake 
continues in a linear fashion over 24 h, but the rate 
of iron accumulation is reduced to -5OYo of control 
values. With methylamine at 10 mM final cont. a 
similar effect is observed. Iron uptake is linear over 
the 24 h incubation period, but the rate of accumula- 
tion of s9Fe is substantially reduced compared to con- 
trol values. 
As pointed out in section 1 the precise site of trans- 
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Fig.3. Kinetics of accumulation of 59Fe (0) and “H (0) 
-labelled material by fibroblasts. Cells (-300 pg proteins) 
were incubated in 7 cm2 Petri dishes, in 0.3 ml culture 
medium containing 100 rg/ml 59Fe-loaded, 3H-labelled trans- 
ferrin and 10 PM chloroquine (A), 100 PM chloroquine (B) 
or 10 mM methylamine (C) for various times at 37°C. Mean 
results of 3 expt A SD. 
ferrin iron release inside the cell is not known, but we 
may suppose that either iron is released at the cell 
membrane subsequent o transferrin binding, or is 
released after interiorisation of the transferrin- 
receptor complex as an endocytic vacuole, possibly 
after fusion of the endocytic vacuole with a lysosome. 
In terms of the second model, transferrin depleted of 
iron would subsequently be returned to the plasma 
membrane and released into the extracellular medium 
[W. 
In cultured mouse peritoneal macrophages, 10 mM 
methylamine and 100 PM chloroquine increase the 
lysosomal pH from 4.8-6.2 [ 151. If iron is released 
from transferrin subsequent o its binding and inte- 
riorisation, we could explain the action of these two 
drugs by assuming that, as in macrophages, they 
increase the lysosomal pH and thereby reduce the 
amount of iron released from transferrin. On the 
other hand it has been shown that 30 mM methyl- 
amine, but not 100 PM chloroquine, inhibits the 
clustering of a-2 macroglobulin and of epidermal 
growth factor at the cell surface of fibroblasts [ 161, 
a step which appears to be preliminary to their endo- 
cytosis. In addition we have observed that these two 
drugs have a considerable effect on the intracellular 
processing of several macromolecules, but do not 
affect their binding to plasma membrane (Y.-J.S., 
A.T., in preparation). These data suggest herefore 
that, in addition to increasing the lysosomal pH, 
methylamine and chloroquine could affect the endo- 
cytosis of transferrin. 
Desferrioxamine B and 2,3-dihydroxybenzoate, 
as well as 2,2’-bipyridyl not only reduce iron uptake, 
but diminish the rate of iron accumulation. We sug- 
gest that these molecules penetrate the plasma mem- 
brane and are able to compete with ferritin, or other 
intracellular acceptors for the iron once it has been 
released from transferrin. Since the resulting iron 
chelators are quite stable and of low molecular weight, 
they may eventually be released from the cells into 
the extracellular medium, thus resulting in a net 
reduction in iron uptake by the cells. 
Bipyridyl may exert its effect on iron accumula- 
tion by a combination of the two effects discussed 
above. By analogy with methylamine and chloroquine, 
it is a weak base and, if it accumulates inside the lyso- 
somes it could increase their pH. It is also an iron 
chelator, and thus could also chelate transferrin iron 
released in lysosomes. At the pH values found in lyso- 
somes bipyridyl is still an extremely effective iron 
chelator. 
These preliminary studies establish that cultured 
rat fibroblasts are a potentially useful system for the 
study of transferrin iron uptake, particularly since 
cell fractionation procedures are well developed [lo]. 
We have found that not only do they accumulate 
transfer&r iron but that drugs, which effect endo- 
cytosis and lysosomal function, and also iron chela- 
tors, inhibit transferrin iron accumulation by the cells. 
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